1,7-phenanthroline has been researched along with Cancer of Pancreas in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cabiddu, MG; Cadoni, E; Gabrielová, V; Havel, J; Masuri, S; Meloni, F; Moráň, L; Pečinka, L; Pivetta, T; Vaňhara, P; Vesselá, T | 1 |
| Banasiak, A; Chatgilialoglu, C; Clynes, M; Colleran, J; Fantoni, NZ; Kellett, A; Kelly, S; Krokidis, MG; McKee, V; Menounou, G; Mitrikas, G; Molphy, Z; O'Carroll, S; Roche, S | 1 |
| Farrelly, ER; Ho, JJ; Kim, YS | 1 |
3 other study(ies) available for 1,7-phenanthroline and Cancer of Pancreas
| Article | Year |
|---|---|
A novel heteroleptic Cu(II)-phenanthroline-UDCA complex as lipoxygenase inhibitor and ER-stress inducer in cancer cell lines.
Topics: Apoptosis; Cell Line; Copper; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Lipoxygenase Inhibitors; Molecular Docking Simulation; Neoplasms; Pancreatic Neoplasms; Phenanthrolines; Ursodeoxycholic Acid | 2023 |
Polypyridyl-Based Copper Phenanthrene Complexes: Combining Stability with Enhanced DNA Recognition.
Topics: Cell Line, Tumor; Coordination Complexes; Copper; Crystallography, X-Ray; DNA; DNA Damage; Electron Spin Resonance Spectroscopy; Humans; Organometallic Compounds; Pancreatic Neoplasms; Phenanthrenes; Phenanthrolines | 2021 |
Phorbol ester reduces phosphorylation of epidermal growth factor receptor in pancreatic cancer cells by activation of a tyrosine phosphatase.
Topics: Cell Membrane; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Humans; Kinetics; Organometallic Compounds; Pancreatic Neoplasms; Phenanthrolines; Phosphorylation; Protein Tyrosine Phosphatases; Quinazolines; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tyrphostins | 1999 |